Cargando…
Osteoarthritis treatment using autologous conditioned serum after placebo: Patient considerations and clinical response in a non-randomized case series
BACKGROUND AND PURPOSE: Autologous conditioned serum (ACS) is a disease-modifying drug for treatment of knee osteoarthritis, and modest superiority over placebo was reported in an earlier randomized controlled trial (RCT). We hypothesized that when given the opportunity, placebo-treated patients fro...
Autores principales: | Rutgers, Marijn, Creemers, Laura B, Yang, Kiem Gie Auw, Raijmakers, Natasja J H, Dhert, Wouter J A, Saris, Daniel B F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366668/ https://www.ncbi.nlm.nih.gov/pubmed/25140983 http://dx.doi.org/10.3109/17453674.2014.950467 |
Ejemplares similares
-
Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection
por: Rutgers, Marijn, et al.
Publicado: (2010) -
Response to: cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection - authors' reply
por: Rutgers, Marijn, et al.
Publicado: (2010) -
Interleukin-6 is elevated in synovial fluid of patients with focal cartilage defects and stimulates cartilage matrix production in an in vitro regeneration model
por: Tsuchida, Anika I, et al.
Publicado: (2012) -
PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation
por: Rutgers, Marijn, et al.
Publicado: (2019) -
Long-term Effect of Injection Treatment for Osteoarthritis in the Knee by Orthokin Autologous Conditioned Serum
por: Zarringam, Danial, et al.
Publicado: (2017)